arabinose has been researched along with Burkitt Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ades, EW; Culwell, M; Hinson, A | 1 |
| Fox, JJ; Otter, BA; Yamaoka, N | 1 |
2 other study(ies) available for arabinose and Burkitt Lymphoma
| Article | Year |
|---|---|
Effector cell sensitivity to sugar moieties. III. Inhibition by monosaccharides of interleukin-2 enhanced natural killing against viral and nonviral tumor target cells.
Topics: Arabinose; Burkitt Lymphoma; Cell Line; Cells, Cultured; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Fucose; Galactosamine; Glucosamine; Humans; Interleukin-2; Killer Cells, Natural; Leukemia, Erythroblastic, Acute; Mannose; Monosaccharides; Rhamnose; T-Lymphocytes, Cytotoxic; Xylose | 1986 |
Nucleosides. XLV. 1-alpha-L-aldo-pentofuranosylpyrimidines.
Topics: Animals; Antineoplastic Agents; Arabinose; Burkitt Lymphoma; Culture Techniques; Cytosine; Humans; Kidney; Leukemia L1210; Liver; Methods; Mice; Nucleosides; Pyrimidines; Thymine; Uracil; Xylose | 1968 |